The objective of this translational study is to evaluate eight femoral arterial cannulae (Medtronic and Maquet, 15 Fr, 17 Fr and 19 Fr compared to Medos: 16 Fr and 18 Fr) using an adolescent/adult extracorporeal life support (ECLS) circuitry.
The current study retrospectively reviewed the Extracorporeal Life Support Organization (ELSO) Registry to evaluate the outcomes following the use of ECMO in patients with cystic fibrosis (CF).